MIM
CLVS

Monashee Investment Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Monashee Investment Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-70,000
Closed -$6.55M – 128
2017
Q2 		$6.55M Buy
+70,000
New +$4.28M 2.77% 11
2017
Q1 		– Hold
0
– – – 62

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Monashee Investment Management's CLVS Position: Q3 2017 in Review

Monashee Investment Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2017, closing a stake of 70,000 shares — an estimated $6.55M sold.

Monashee Investment Management first reported a position in CLVS in Q2 2017 and held it in 1 quarter. The position peaked at $6.55M in Q2 2017. 255 funds tracked by Wall St. Rank hold CLVS as of Q3 2017.

  • Monashee Investment Management reported no remaining Clovis Oncology, Inc. position as of Q3 2017 after selling out during the quarter.
  • Monashee Investment Management sold 70,000 Clovis Oncology, Inc. shares in Q3 2017, an estimated $6.55M.
  • Monashee Investment Management first reported a position in Clovis Oncology, Inc. in Q2 2017 and held it in 1 quarter.
  • Monashee Investment Management's Clovis Oncology, Inc. position peaked at $6.55M in Q2 2017.
  • 255 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2017.

Based on Monashee Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.